✦ LIBER ✦

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

✍ Scribed by A.Michael Lincoff; John A Bittl; Neal S Kleiman; Ian J Sarembock; J.Daniel Jackman; Sameer Mehta; Mark A Tannenbaum; Alan L Niederman; William B Bachinsky; J Tift-Mann III; H.Graham Parker; Dean J Kereiakes; Robert A Harrington; Frederick Feit; Elizabeth S Maierson; Derek P Chew; Eric J Topol

Book ID: 113440876
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 107 KB
Volume: 93
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.01.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Bivalirudin During Percutaneous C

Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus: An Analysis From the Randomized Evaluation in Percutaneous Coronary Intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 Trial

✍ Hitinder S. Gurm; Ian J. Sarembock; Dean J. Kereiakes; John J. Young; Robert A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Ischemic and bleeding outcomes in women

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: A subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ Matthews Chacko; A. Michael Lincoff; Katherine E. Wolski; David J. Cohen; John A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Outcomes of patients with acute coronary

Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial

✍ Vivek Rajagopal; A. Michael Lincoff; David J. Cohen; Hitinder S. Gurm; Tingfei H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Provisional glycoprotein IIb/IIIa blocka

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

A randomized two-by-two comparison of hi

A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: The tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial

✍ David J. Moliterno;; the TENACITY Steering Committee; Investigators 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views